Home

Kyle Gano, CEO: Neurocrine Biosciences NBIX Sell · Filed 25/02/14

Trade details

Type
Insider sale
Amount
$157,967.68
Shares · price
1,352 sh · $116.84 a share
Held after
138,872 sh
Trade date
25/02/13
Filed
25/02/14
Days to filing
1 days

Sold 1.0% of holdings

Share of holding sold
1.0%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/01/14~25/03/15

Kyle Gano's recent trades

  • Kyle Gano

    Sell10b5-1 planNeurocrine Biosciences

    $4.6M

    Filed 01/20

  • Kyle Gano

    Sell10b5-1 planNeurocrine Biosciences

    $240.5K

    Filed 01/20

  • Kyle Gano

    Planned sale10b5-1 planNeurocrine Biosciences

    $4.9M

    Filed 01/16

  • Kyle Gano

    Planned sale10b5-1 planNeurocrine Biosciences

    $42.6K

    Filed 25/11/05

  • Kyle Gano

    SellNeurocrine Biosciences

    $42.6K

    Filed 25/11/04

Kyle Gano, CEO — sold $158K of Neurocrine Biosciences NBIX · 1.0% of holdings · 10b5-1 plan | Whalegun